Strategic Collaboration Potential cross-selling with harm reduction partners and healthcare distributors by offering rapid membrane tests and immunoassay capabilities to organizations like DanceSafe and other harm reduction or clinic networks.

Fast Growth Opportunity Mid-sized manufacturing firm with revenue in the 10-25 million range and a GMP-certified in vitro diagnostic facility, indicating capacity to scale partnerships, co-development, and regional distribution in California and beyond.

Regulatory Trust FDA GMP designation for in vitro diagnostics provides a credibility lever when approaching hospital networks, clinics, and government programs seeking compliant rapid test solutions.

Product Leadership One-step rapid membrane tests and immunoassays position the company to target urgent care, EMS, harm-reduction nonprofits, and field testing programs that require easy-to-use, low-cost diagnostics.

Strategic Market Fit Proximity to Los Angeles and established manufacturing footprint can support regional sales efforts, white-labeling, and partnerships with regional distributors serving medical, educational, and event-related testing needs.